Evidence map›Paper›PMID 30701048›Full record

ReviewJournal of xenobiotics2016

Pharmaceutical Compounds in Drinking Water.

Vikas Chander, Bhavtosh Sharma, Vipul Negi, Ravinder Singh Aswal, Prashant Singh, Rakesh Singh, Rajendra Dobhal

Abstract readReview
In one paragraph

Review in Journal of xenobiotics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Lattice oxygen-mediated ABORSC advances · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Synthesis of GG-Journal of environmental health science & engineering · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Novel PVDF-PEG-CaCOMembranes · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vikas ChanderDepartment of Chemistry, DAV (PG) College, Dehradun, Uttarakhand.
Bhavtosh SharmaUttarakhand Science Education and Research Centre (USERC), Dehradun, Uttarakhand.
Vipul NegiDepartment of Chemistry, DBS (PG) College, Dehradun, Uttarakhand.
Ravinder Singh AswalDepartment of Environmental Sciences, Gurukula Kangri Vishwavidyalaya, Haridwar, Uttarakhand.
Prashant SinghDepartment of Chemistry, DAV (PG) College, Dehradun, Uttarakhand.
Rakesh SinghDepartment of Chemistry, DBS (PG) College, Dehradun, Uttarakhand.
Rajendra DobhalUttarakhand Council for Science and Technology (UCOST), Dehradun, Uttarakhand, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical products and their wastes play a major role in the degradation of environment. These drugs have positive as well as negative consequences on different environmental components including biota in different ways. Many types of pharmaceutical substances have been detected with significant concentrations through various advanced instrumental techniques in surface water, subsurface water, ground water, domestic waste water, municipal waste water and industrial effluents. The central as well as state governments in India are providing supports by creating excise duty free zones to promote the pharmaceutical manufacturers for their production. As a result, pharmaceutical companies are producing different types of pharmaceutical products at large scale and also producing complex non-biodegradable toxic wastes byproducts and releasing untreated or partially treated wastes in the environment in absence of strong regulations. These waste pollutants are contaminating all types of drinking water sources. The present paper focuses on water quality pollution by pharmaceutical pollutants, their occurrences, nature, metabolites and their fate in the environment.

Indexed as

fate and water pollutionPharmaceutical effluentpharmaceutical global market

Identifiers

PMID30701048
PMCPMC6324466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.